OUR RESOURCES
Video and slides 
CRSF Asco list of publications 
Ongoing studies 
Complete studies 9th Annual Year End Review In Lung Cancer 2025
View DetailsIMforte: Maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small cell lung cancer (SCLC) vs atezolizumab alone.
DeLLphi-304: Phase 3 of tarlatamab vs chemotherapy for SCLC after progression on platinum-based therapy.
DeLLphi?303: Tarlatamab with first?line chemo?immunotherapy for ES?SCLC.
LYMPHOMA GRAND ROUNDS
View DetailsOncology Insights 2025
View DetailsBhagwan Birsa Munda Cancer Conclave
View DetailsOncology Conundrums 4.0-Delhi
View Details